title: Potential shortage of supplemental test kits for detecting HIV-1 antibodies.
abstract: The Public Health Service has become aware of a potential shortage of supplemental test kits used for confirmatory testing of human immunodeficiency virus (HIV) antibodies in specimens obtained from either patients or blood and plasma donors. On April 17, 2002, Calypte Biomedical Corporation (Alameda, California) announced the company might stop manufacturing the Cambridge Biotech HIV-1 Western blot kit. The distributor, bioMérieux, Inc. (Durham, North Carolina), immediately notified customers that it no longer would be able to distribute the Cambridge Biotech HIV-1 Western blot kit.
mesh_terms: D015492:AIDS Serodiagnosis / Q000295:instrumentation*; D015483:HIV Antibodies / Q000032:analysis; D015497:HIV-1 / Q000302:isolation & purification; D006801:Humans; D011933:Reagent Kits, Diagnostic / Q000600:supply & distribution*; D014481:United States
chemical_list: D015483:HIV Antibodies; D011933:Reagent Kits, Diagnostic